Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update.

Saved in:
Bibliographic Details
Title: Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update.
Authors: Gittus M; University of Sheffield, Sheffield, United Kingdom. mjgittus1@sheffield.ac.uk.; Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom. mjgittus1@sheffield.ac.uk., Haley H; University Hospitals of North Midlands, Birmingham, United Kingdom., Harris T; PKD Charity, London, United Kingdom., Borrows S; Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom., Padmanabhan N; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Gale D; Royal Free London NHS Foundation Trust, London, United Kingdom., Simms R; Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom., Williams T; University of Sheffield, Sheffield, United Kingdom., Acquaye A; Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom., Wong A; Royal Free London NHS Foundation Trust, London, United Kingdom., Chan M; Imperial College Healthcare NHS Trust, London, United Kingdom., Lee E; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Ong AC; University of Sheffield, Sheffield, United Kingdom. a.ong@sheffield.ac.uk.; Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom. a.ong@sheffield.ac.uk.
Source: BMC nephrology [BMC Nephrol] 2025 Feb 14; Vol. 26 (1), pp. 79. Date of Electronic Publication: 2025 Feb 14.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2369
DOI:10.1186/s12882-025-03960-4